<DOC>
	<DOC>NCT01139008</DOC>
	<brief_summary>The purpose of this study is to compare the tolerability of MetroGel® (metronidazole gel) 1% to Finacea® (azelaic acid) Gel 15% in subjects with healthy skin applied according to product labeling for three weeks.</brief_summary>
	<brief_title>Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin</brief_title>
	<detailed_description />
	<mesh_term>Skin Manifestations</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Healthy male and female adults (ages 18 years or older) Subjects with healthy skin as determined by the clinical grader Subjects with a degree of skin pigmentation that interferes with the reading of skin reactions Subjects with known allergy to one of the components of the study drugs (refer to the package inserts for MetroGel® 1% and Finacea® Gel 15%) Subjects who have participated in another investigational drug or device research study within 30 days of enrollment Subjects with a washout period for topical treatment on the treated area less than 1 week for corticosteroids and/or 4 weeks for retinoids Subjects with a washout period for systemic treatment less than 1 week for medications that may increase photosensitivity and/or 4 weeks for corticosteroids and/or 6 months for retinoids Subjects with current sunburn, eczema, atopic dermatitis, perioral dermatitis, rosacea, or other topical conditions on the area to be treated Subjects who foresee unprotected and intense UV exposure during the study (mountain sports, UV radiation, sunbathing, etc.)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>